Last update 23 Jan 2025

Jiangsu Xiansheng Biopharmaceutical Co., Ltd.

Private Company|
2017|
Jiangsu Sheng, China
|
www.simcere.com

Overview

Tags

Neoplasms
Immune System Diseases
Endocrinology and Metabolic Disease
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Monoclonal antibody2
Top 5 TargetCount
TNFR2(Tumor necrosis factor receptor superfamily member 1B)1
VEGF x VEGF-A1

Related

2
Drugs associated with Jiangsu Xiansheng Biopharmaceutical Co., Ltd.
Sevacizumab
Target
VEGF x VEGF-A
Mechanism
VEGF inhibitors [+1]
Active Org.
Jiangsu Simcere Pharmaceutical Co., Ltd.Jiangsu Simcere Pharmaceutical Co., Ltd. [+3]
Originator Org.
Epitomics, Inc.Epitomics, Inc.
Active Indication
Fallopian Tube Carcinoma [+6]
Inactive Indication
Advanced Malignant Solid Neoplasm [+3]
Drug Highest PhaseNDA/BLA
First Approval Ctry. / Loc.-
First Approval Date-
SIM1811-03
Target
TNFR2
Mechanism
TNFR2 modulators
Active Org.
Jiangsu Xiansheng Biopharmaceutical Co., Ltd. [+1]
Originator Org.
Jiangsu Xiansheng Biopharmaceutical Co., Ltd.
Active Indication
Advanced cancer [+2]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Jiangsu Xiansheng Biopharmaceutical Co., Ltd.
CTR20220519
/ RecruitingPhase 1
评估SIM1811-03在晚期肿瘤患者中的安全性，有效性和药代动力学/药效动力学特征的开放，多中心Ⅰ期临床研究
[Translation] An open, multicenter Phase I clinical study to evaluate the safety, efficacy, and pharmacokinetic/pharmacodynamic characteristics of SIM1811-03 in patients with advanced tumors
100 Clinical Results associated with Jiangsu Xiansheng Biopharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Jiangsu Xiansheng Biopharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Jiangsu Xiansheng Biopharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Jiangsu Xiansheng Biopharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
NDA/BLA
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Sevacizumab
 ( VEGF x VEGF-A )		Recurrent ovarian cancer
More
NDA/BLA
SIM1811-03
 ( TNFR2 )		Advanced Malignant Solid Neoplasm
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free